【Precision Testing = Social Responsibility】14-Panel STD Test Kit: Solve 95% Of STI Risks In One Test, Empowering Market Growth

【Precision Testing = Social Responsibility】14-Panel STD Test Kit: Solve 95% of STI Risks in One Test, Empowering Market Growth

Sexually transmitted diseases (STDs) are a growing global health threat:

• WHO data shows over 1 million new STD infections daily, with 70% asymptomatic (e.g., HPV, chlamydia).
• Undiagnosed STDs can lead to infertility, cancer progression (e.g., HPV→cervical cancer), and neonatal complications.

Yet traditional testing faces three critical challenges: 

❌ Single-pathogen tests are inefficient with high miss rates.

❌ Hospital workflows are cumbersome, raising privacy concerns.

❌ Grassroots clinics lack testing capacity.

——

The Cowingene STD 14-Panel Test Kit breaks the mold with: 

✅ Comprehensive coverage: Detects 14 high-risk pathogens (HPV/HSV/gonorrhea/syphilis, etc.) at ≥99.2% sensitivity (CE-certified).

✅ High efficiency: Compatible with urine/swab samples and mainstream PCR systems (ABI 7500, Bio-Rad, etc.), delivering results in 1.5 hours.

✅ Market-ready advantages:

• For distributors: Differentiate your portfolio in the fast-growing POCT market (3% CAGR).
• For clinics: Enhance competitiveness with privacy-conscioushealth services.

Why act now?

• Policy tailwinds: Countries are integrating STD screening into public health programs (e.g., China’s "Healthy China 2030" initiative).
• Consumer shift: Gen Z’s willingness to pay for preventive testing surged 320%(2023 Deloitte Report).

We deliver more than a kit—we provide solutions: 

📊 Custom marketing materials (IFU, user manuals).

🛠️ End-user training (sampling protocols, equipment operation).

"Prevention outweighs treatment." Partner with us to advance public health, not just supply products.

📩 Contact us → [marketing@cowingene.com]